Google Inc agreed to pay $500 million to settle US allegations that advertising for online Canadian pharmacies on its website allowed illegal imports of prescription drugs.
Google, based in Mountain View, California, was aware as early as 2003 that the shipment of prescription medicines to the US from outside the country is illegal, the Department of Justice said in a statement on Wednesday.
“We banned the advertising of prescription drugs in the US by Canadian pharmacies some time ago,” Google said in an e-mailed statement. “However, it’s obvious with hindsight that we shouldn’t have allowed these ads on Google in the first place. Given the extensive coverage this settlement has already received, we won’t be commenting further.”
Google announced in February 2010 that it would only accept US and Canadian ads from pharmacies certified by the National Association of Boards of Pharmacy’s Verified Internet Pharmacy Practice Sites program, known as VIPPS, and the Canadian International Pharmacy Association.
In December 2010, Google joined Microsoft Corp, Yahoo! Inc and other companies in helping establish a non-profit organisation to fight illegal Internet pharmacies. Counterfeit drug sales account for about $75 billion in global sales, the National Association of Boards of Pharmacy said at the time. About 1 per cent to 2 per cent of drugs in North America are counterfeit, according to the pharmacy group.
“The result of this investigation has been a fundamental transformation of Internet pharmacy advertising practices, significantly limiting promotion to US consumers by rogue online pharmacies,” said Kathleen Martin-Weis, acting director of the Food and Drug Administration’s Office of Criminal Investigations, in the statement.
Google said in May that it had set aside $500 million for the resolution of an investigation of its ad business.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
